TRUST TRIAL

The TRUST study is a phase 1b trial designed to assess the pharmacokinetics (PK), tolerability, and safety of oral trimetazidine administered to subjects with Acute Decompensation (AD), or with ACLF Grades 1 and 2 with liver failure or coagulation failure and a range of renal function.